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Abstract
The goal of this workshop is to develop a consensus within the biomaterials/bioengineering
community for a research agenda focused on creating technologies that will address the current
dental caries pandemic. The workshop will bring together expertise from academia, industry, and
the NIH institutes in the areas of oral biofilm microbiology and innovative biomaterials. The
rationale for the workshop is that science and technology have not produced sufficient practical
tools for public health practitioners and the private delivery system to address the pandemic in
dental caries that exists for children and adults from families with low incomes and for numerous
ethnic minority and racial groups. Moreover, it is unclear whether the barriers are remediable
bioengineering and technical problems or fundamental science questions. Nevertheless, the
obligation to address the gap between scientific research and practical application is especially
relevant today. The U.S. and state governments bear the majority of the cost of trying to control
this pandemic through Medicaid, the Public Health Service, Indian Health Service and other similar
programs. These costs continue to escalate as continued applications of existing technology are
unlikely to markedly reduce disparities. The mainstays of caries prevention, topical and systemic
fluorides and pit and fissure sealants, are technologies developed in the 1950s and 1960s.
Introduction
The caries process has been well understood since 1960
when Fitzgerald and Keyes demonstrated in animals that
acidogenic bacteria are transmitted from mother to off-
spring and between animals sharing the same cage [1].
These bacteria metabolize carbohydrates and produce
acid, which in turn leads to demineralization of dental
enamel. Dental caries is thought to be an almost com-
pletely preventable disease. Prevention requires minimiz-
ing the frequency of ingesting simple carbohydrate foods
and beverages, regular oral hygiene measures to remove
plaque and to introduce topical fluoride in the form of
toothpaste, and flossing to remove plaque and debris
from between the teeth. It is recognized that even when
the appropriate preventive measures are taken, there are
some individuals who have increased susceptibility to
dental caries.
At a group level, people living in poverty, ethnic and racial
minorities, and recent immigrants to the U.S. are at
increased risk for dental caries. There is also evidence that
people with poor access to dental care are at increased
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risk. In children, dental caries is the most common
chronic illness and is five times more common than
asthma [2].
The discovery of the role of fluoride in dental caries pre-
vention led to significant decreases in caries prevalence in
the U.S. and many other countries as a result of commu-
nity water fluoridation and the widespread use of fluori-
dated toothpaste [3]. At the turn of the current century,
the U.S. Centers for Disease Control and Prevention deter-
mined that water fluoridation was one of the top 10 pub-
lic health achievements of the century [4].
In the last decade, there has been an increased interest in
research related to microbial biofilms as well as in bioen-
gineering and biotechnology. It has become increasingly
evident that dental researchers need to look beyond their
traditional mind set and investigate the opportunities for
collaborating with researchers outside of dentistry in
order to bring new insights to the prevention and manage-
ment of a disease that continues to affect a large percent-
age of the population in all countries of the world.
This need for a new, innovative approach to the manage-
ment and prevention of dental caries resulted in the
National Institute for Dental and Craniofacial Research
(NIDCR) and others providing funding for an interdisci-
plinary conference on biotechnology, biomaterials, and
dental caries (Dr. Peter Milgrom, P.I.). The purpose of this
conference was to develop a research agenda that will lev-
erage new discoveries and lead to innovative approaches
to reduce caries in high risk populations. An esteemed
group of internationally recognized scientists representing
cariology, behavioral sciences, bioengineering, and
microbiology were invited to present research on topics
aimed at developing a better understanding of this multi-
factorial disease. Emphasis was placed on the develop-
ment of interdisciplinary collaboration between dentistry
and bioengineering.
There were 57 participants including 34 nationally and
internationally known scientists, four dental practition-
ers, four representatives from the dental industry and 15
graduate and undergraduate students. The meeting was
spread out over two and a half days with four plenary ses-
sions and three breakout sessions.
Two keynote lectures were given during lunch on the sec-
ond day and breakfast on the third day, respectively. The
first lecture was given by Pierre Mourad, PhD, Principal
Physicist, Applied Physics Laboratory, Research Associate
Professor, Department of Neurological Surgery, Univer-
sity of Washington School of Medicine and was entitled
"Translational Medical Research: Examples and Lessons."
Dr. Mourad discussed important considerations when
moving a research method or device from the laboratory
into market. Since he has gone through this process with
a number of his own inventions, he was able to provide
valuable tips to the participants.
The second lecture was given by Christopher J. Elias, MD,
MPH – President, Program for Appropriate Technology in
Health (PATH). His talk was entitled "Public-Private Part-
nerships to Advance Technologies for Neglected Dis-
eases." In his talk, Dr. Elias emphasized that partnerships
with private companies must be in keeping with the mis-
sion of PATH and must "lead to positive impact on avail-
ability, accessibility, and affordability of important health
products for public health programs in developing coun-
tries." He also pointed out the importance of recognizing
the need for profitability for the private company and that
"PATH must recognize the company's need for commer-
cial benefit in order to ensure a sustainable commitment
to the collaboration." He used the example of the menin-
gitis vaccine project in which PATH, with a grant from the
Bill and Melinda Gates Foundation, partnered with the
World Health Organization and an emerging vaccine
manufacturer in India to produce an affordable vaccine
for use in Sub-Saharan Africa. In this initiative and in
many others, PATH has demonstrated that public-private
partnerships are an effective means to advance technolo-
gies to treat neglected diseases. This is particularly relevant
for dental caries since it is prevalent in both developed
and underdeveloped nations and frequently affects indi-
viduals with the least ability to access limited resources.
It was clear from the presentations at this conference that
there have been major advances in both biotechnology
and bioengineering in the last decade. The themes that
presenters were asked to address were divided into three
general categories: 1) ways to modify or enhance existing
technologies (fluoride- or xylitol-related) to make them
more effective; 2) development of new targets or novel
strategies (related to adhesion, oral ecology, or probiot-
ics); 3) development of new technologies or delivery sys-
tems (related to anti-adhesives or fluoride replacement
methodologies).
Presenters discussed emerging research in the prevention
of dental caries including: specific species bacterial adhe-
sion prevention, biofilm ecology manipulation, targeting
of microbial species using lytic enzymes, probiotics using
natural anti-microbial peptides, circumvention of
sucrose-driven acid production, and fluoride- and other
antimicrobial-release coatings. These topics were the
focus of discussion during the conference and informed
the breakout sessions each day.BMC Oral Health 2006, 6:S1
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Challenges to Participants
The conference opened with remarks from Dr. Peter Mil-
grom, followed by a series of talks that described the chal-
lenges faced by clinicians and researchers in their efforts to
minimize the impact of dental caries. Dr. Burton Edelstein
discussed the term "pandemic" and the appropriateness
of using this term to describe dental caries. He made the
point that use of the term "caries pandemic" suggests a
disease that is highly prevalent globally and has severe
consequences to society. He also initiated the discussion
of caries being a disease that is amenable to prevention
and that is experienced disproportionately within the
population, with poor and disadvantaged people being
more frequently affected. This theme was continued and
refined by Dr. Clemencia Vargas who defined health dis-
parities as the occurrence of a disproportionate share of
the burden of health being received by one particular
group of people. She went on to describe Early Childhood
Caries (ECC) as a disease with disparities in both the prev-
alence and treatment. Dr. Vargas presented compelling
data to show that when white children are compared to
non-white children in the U.S., non-white children have a
greater caries experience and a higher level of untreated
caries.
Dr. Donald Patrick presented a theoretical framework for
understanding and investigating disparities in oral health.
This model, which discusses the various factors that con-
tribute to oral health and disease and identifies interven-
tions that target each of these factors, will bring new
direction for research and policy that is focused on reduc-
ing oral health disparities.
Evidence shows that education alone is not sufficient to
change behavior. Since a significant component of dental
disease is related to behaviors such as diet, oral hygiene,
and fluoride exposure, it makes sense that any strategy to
improve oral health must improve health-related behav-
iors. Dr. Philip Weinstein's presentation on motivational
interviewing as a technique to assess a person's readiness
to change and to subsequently effect that change, was an
important reminder to all participants that any solution to
dental caries must consider adherence or lack of adher-
ence by individuals. He also discussed this same theory
relative to the practitioner's readiness to change, as fre-
quently there are effective methods to prevent dental car-
ies that dentists choose not to incorporate into their
practices.
The final presentation in this section was by Dr. Joel Berg
and was focused on the opportunities for developing and
marketing new technologies for caries prevention. Dr.
Berg emphasized the importance of knowing the market
and identifying unmet needs on the part of both the buyer
and seller. Once this is accomplished, then the market
should be divided into segments, and the particular seg-
ment of interest can be targeted. The dental market in the
U.S. is approximately $80 Billion, and 20 percent of this
market is for consumer or professional products. In terms
of categories of expenditures, 60 percent of the total
expenditures are for either the results or effects of dental
caries. As caries detection technologies become more sen-
sitive, there will be greater opportunities to manage the
caries process (to remineralize the enamel surface) rather
than to intervene surgically. In general, the market for new
products (such as early detection devices) is very difficult.
The marketplace will ultimately not be receptive to these
newer highly sensitive tools, even with increased specifi-
city, unless the appropriate compensation systems are in
place.
Delivery Challenges for Caries Preventive Agents
Caries preventive agents, such as fluorides and chlorhexi-
dine, have been shown to be very effective at remineraliz-
ing surface enamel or controlling cariogenic bacteria,
respectively. However, both of these agents rely on patient
compliance at home or regular visits to the dentist. Recent
studies also show promise for other agents such as xylitol
(a sugar alcohol) and amorphous calcium phosphate in
toothpaste and chewing gums. All of these agents require
action on the part of the patient in order to have the
desired effect. Some are not particularly palatable. That is,
the characteristics of both the agent and the delivery sys-
tem have an impact on its effectiveness, and current
approaches might be redesigned to advantage.
The first plenary session of the conference focused on
delivery challenges associated with proven preventive
agents. In his talk, Dr. John Featherstone discussed the
shortcomings of current delivery methods, including the
short duration of therapeutic levels of fluoride and chlo-
rhexidine when administered as a varnish or rinse and the
need for ways to deliver these agents over an extended
period of time. Xylitol has been shown to be effective
when consumed as a gum or lozenge, but neither of these
delivery methods is appropriate for an infant. In his pres-
entation, Dr. Featherstone argued for research focusing on
strategies that combine agents that would be desirable
because the effectiveness of fluorides in remineralization
would be enhanced if the bacterial load were reduced first.
The traditional delivery mechanisms for fluorides and
other remineralizing agents have been in dentifrices and
mouth rinses. Dr. Domenick Zero discussed the regula-
tory issues related to getting approval for adding new car-
iostatic agents to toothpaste or mouth rinses as they are
tested and found to be effective. Dr. Zero identified a
number of factors that interfere with the development of
the most effective caries preventive agents for the U.S.
including: 1) U.S. Food and Drug Administration guide-
lines that focus on safety and efficacy (not level of effi-BMC Oral Health 2006, 6:S1
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cacy); 2) rising costs of clinical trials; 3) Laboratory testing
requirements that use antiquated methods which no
longer reflect our current understanding of the action of
fluoride. In his paper, he recommends that oral health dis-
parities can be addressed by making certain that at-risk
individuals are obtaining the maximum benefit from flu-
oride dentrifice by making available the most effective
products and educating individuals on how to obtain the
greatest benefit.
Dr. Per Axelsson reported the results of a 20-year study
that implemented a caries-preventive program for chil-
dren in different age groups or developmental stages.
Risks were associated with initial acquisition of mutans
streptococci in infants, eruption of first permanent molars
in 5–7-year-olds, and eruption of second permanent
molars in 11–13-year-olds. Individual risk for caries was
determined annually, and those children considered at
high risk were given additional preventive interventions
including fluoride varnish application and more frequent
professional mechanical tooth cleaning. This program has
been very successful in reducing the caries experience in
children in Varmland, Sweden. Among 19-year-olds cross
sectionally, the average caries prevalence was reduced
from more than 24 DFS in 1979 to only 2 DFS in 1999.
This study is an example of how our current technologies,
applied intensively on a risk basis in schools and public
dental health centers and timed to coincide with the erup-
tion of new, susceptible tooth surfaces, can be very effec-
tive at reducing the burden of disease.
Dental Caries Microbiology
Very early in the study of dental caries (in the late 19th cen-
tury), W.D. Miller recognized that enamel demineraliza-
tion was mediated by a mixed bacterial infection in whole
saliva [5]. What he didn't know was which bacterial spe-
cies were responsible for metabolizing carbohydrates,
converting sugar to acid and leading to demineralization
of dental enamel. The identification of Streptococcus
mutans as a possible caries-causing agent occurred much
later [1] and has since been expanded to include other
Streptococci species, referred to collectively as mutans strep-
tococci [6]. Caries research since that time has focused pri-
marily on mutans streptococci as a target for prevention of
disease through the use of anti-microbial agents, vaccines,
and probiotics.
The second plenary session focused on new technologies
and approaches used to understand the microbiology of
dental caries and ways to interfere with the caries process.
Dr. David Stahl discussed the composition of the oral bio-
film and the evidence that this biofilm is inhabited by
more than 600 microbial species. Less than half of these
bacteria are cultivatable by traditional means. Dr. Stahl's
laboratory uses microchip technology to identify bacteria
within the biofilm and to determine their relative fre-
quency within plaque samples.
Dr. Howard Kuramitsu discussed the importance of inter-
actions between S. mutans and other biofilm constituents
in determining the cariogenicity of plaque samples. In
particular, his laboratory investigated the ability of S. gor-
donii to weaken some of the properties of S. mutans that
contribute to its virulence, including its ability to produce
bacteriocin, its ability to form a biofilm, and its ability to
transform its genetic makeup. Research regarding these
strategies, he argued, may be valuable in findings meth-
ods to control or manage dental caries in some individu-
als. Additional strategies were suggested by Dr. Phil
Marsh, who focused on the importance of understanding
oral ecology and the factors that disrupt microbial home-
ostasis as an essential part of caries control mechanisms.
He asserted, in his lecture, that it is necessary to identify
critical control points on an individual basis in order to
interfere with the disease process rather than just treating
the consequence of disease.
Research on oral biofilms is essential to the understanding
of dental caries. Biofilms are composed of multiple bacte-
rial species that adhere to a solid surface (the tooth) and
are held together by a matrix of extracellular polymeric
substances (EPS). Characteristics of biofilms that make
their control challenging include the increased resistance
to antimicrobial agents of the bacteria within the biofilm
and the rapidity of re-colonization after mechanical
removal. Dr. John Cisar presented research from his lab
regarding the bacteria that initiate colonization of tooth
surfaces. His lab identified streptococcal receptor polysac-
charides (RPS) that interact with viridans group strepto-
cocci  and  Actinomyces naeslundii in early biofilm
formation. Understanding this important component of
the biofilm and how it differs from one individual to
another may provide new insights and through research
lead to new approaches to the management and preven-
tion of dental caries.
The recognition that antimicrobial peptides are present in
saliva provides some interesting possibilities for the man-
agement of oral diseases such as dental caries and perio-
dontal disease. Dr. Beverly Dale-Crunk measured levels of
antimicrobial peptides in school-aged children with or
without dental caries. In her study, she found that mean
levels of alpha-defensins were significantly higher in some
children without caries than in other children with caries.
These results, she argues, suggest possibilities both for
early detection of caries risk and for early preventive strat-
egies through research.BMC Oral Health 2006, 6:S1
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Emerging Technologies
Technologies with the potential to prevent or manage
dental caries could take a number of forms, including
ways to detect caries risk prior to disease occurrence, spe-
cies-specific targeting of acidogenic bacteria, reduction of
bacterial adherence to tooth surfaces, and prolonged
release of therapeutic agents. Interdisciplinary research
that combines the expertise of dentistry, molecular biol-
ogy, and bioengineering holds great promise for new,
innovative approaches to the prevention of dental caries.
Dr. Vincent Fischetti presented a study on the use of bac-
teriophage lytic enzymes to control pathogenic bacteria.
These enzymes are species specific and are capable of
destroying large numbers of bacteria in blood or on
mucosal surfaces in seconds. They target the bacterial cell
wall of the specific bacteria they were developed from and
do not attack human cells. Lytic enzymes have many
potential uses in the food industry, in hospitals and nurs-
ing homes, and in the treatment of diseases such as dental
caries that are mediated by bacteria. He suggested that an
enzyme specific to S. mutans is being developed.
One of the key ingredients in the caries process is diet. A
diet rich in sugars and simple carbohydrates provides the
oral bacterial with a substrate from which they produce
acid. Recent evidence suggests that a person's preference
for sweet-tasting foods is more complex than simply what
foods or sweets the child is exposed to early in life. Dr.
Danielle Reed demonstrated in her work that sweet per-
ceptions and preferences have an important genetic com-
ponent, suggesting that some people may actually have a
"sweet tooth." Having the genetic makeup that leads to a
preference for sweet-tasting foods does not necessarily
predict the choices an individual will make. It does, how-
ever, suggest another potential avenue for the investiga-
tion of risk factors leading to dental caries.
Technologies to control biofilm formation have been
developed in many disciplines other than in dentistry.
Management or elimination of microbial biofilms is
important in fields as diverse as medicine and the boating
industry. In the boating industry the management of bio-
films has led to the development of anti-fouling polymers
such as poly(ethylene glycol) (PEG), or a poly(N-substi-
tuted glycine) (polypeptoid). Dr. Phil Messersmith dis-
cussed his research with these polymers and how these
technologies may have interesting possibilities for the
management of oral biofilms and dental disease.
Dr. Buddy Ratner expanded on the topic of anti-adhesive
polymers and discussed a number of other strategies that
have potential with future research for disrupting the oral
biofilm or delivering therapeutic agents in a controlled-
release manner. The controlled delivery systems he dis-
cussed include passive delivery systems and responsive
drug delivery systems. Examples of the passive systems
include diffusion-controlled systems wherein the drug is
either in a reservoir device surrounded by an inert barrier
or membrane or the drug is dissolved in an inert polymer.
Another type of passive system is chemically controlled. A
bioerodible system is used to hold and subsequently
release the drug. Responsive drug delivery systems are
either open- or closed-loop systems. Open-loop systems
are regulated externally using magnetism or ultrasound.
In closed-loop systems, the release is in response to local
conditions such as temperature, pH, or other factors.
Advances in understanding of the caries process and of the
many new engineered biomaterials has provided many
future opportunities for collaborative efforts aimed at
eliminating dental caries in the most susceptible individ-
uals.
Future Goals
One of the stated goals of this conference was to develop
a research agenda that, if adopted by investigators and
funders, will leverage recent discoveries and lead to inno-
vative new approaches to reduce caries in high-risk popu-
lations. To allow discussion leading to a research agenda,
there were three breakout sessions with three sub-topics in
each session. Participants were charged with identifying
1) ways to enhance existing technologies; 2) new targets
or novel strategies and 3) new technologies or delivery
systems to decrease the incidence of dental caries. Strate-
gies identified in the breakout sessions were then organ-
ized into specific topics that could inform a future request
for applications from government, foundations, or indus-
try in the area of biotechnology and bioengineering
approaches to reduce disparities in dental caries.
Studies that would be responsive to the goals of this RFA
would include but not be limited to the following:
Enhancing Existing Technologies
• Methods to improve the substantivity of topical fluo-
rides; techniques to enhance the diffusion of fluoride into
plaque; innovative, controlled release delivery devices;
combinations of fluoride and antimicrobial therapies;
and high-concentration fluoride varnishes.
• Education programs to inform the public and the health
care community about disease management and preven-
tion using psychological approaches, including motiva-
tional interviewing and other approaches used effectively
outside the field of oral health.
• Clarification and enhancement of mechanisms of action
v/v inhibition of acid production and glucan production.BMC Oral Health 2006, 6:S1
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• Development of toothpaste with fluoride encapsulated
in controlled-release "microcapsules" substantive to
plaque, or pellicle/tooth surface.
• Formulation of toothpastes with complimentary agents
such as lytic enzymes or anti-microbial peptides.
• Incorporation of novel technology such as quorum sen-
sors, adherence inhibitors, bacterial toxins, and polymer-
releasing salicylic acid derivatives.
Development of New Targets or Novel Strategies
• Methods to effectively balance the oral ecology through
the delivery and retention of agents such as antimicrobial
peptides, arginine, urea, and fluoride.
• Methods to identify the full range of oral bacteria and
understand the metabolic activity of acidogenic species.
• Methods to recognize and inhibit virulence factors.
• Methods to inhibit metabolic pathways and to deliver
and retain buffers in plaque.
• Development of delivery systems that can be done at
home – rinse, brush or wipes.
• Enhanced production of antimicrobial peptides.
• Development of probiotic approaches such as introduc-
ing S. gordonii prior to establishment by Mutans strepto-
cocci.
• Development of novel methods to target Mutans strepto-
cocci such as lytic enzymes, competence-stimulating pep-
tide (CSP), and mutacin.
• Identification and development of lytic enzymes to tar-
get other acid producing oral bacteria.
• Identification of biomarkers for inhibitors of quorum
sensing and for inhibitors of bacterial metabolism.
• Development of new delivery systems to provide for dis-
tribution throughout the mouth and release over
extended periods of time.
• Development and testing of antiadhesive coatings for
controlling oral biofilms, including research to define the
chemical and structural characteristics desired in antifoul-
ing polymers.
• Development and testing of the chemical and structural
characteristics of glycoproteins and polysaccharides
present in oral biofilms.
Development of New Technologies or Delivery Systems
• Modification of xylitol delivery systems to reduce the
number of doses while maintaining its effect.
• Research to understand how xylitol is affecting the bac-
terial ecology in plaque and saliva.
• Development and testing of the efficacy of sustained
release of xylitol.
• Testing the ability of small molecular-weight antimicro-
bial compounds (peptides, etc.) tethered to antifouling
polymers to be active in controlling bacterial colonization
and biofilm formation.
• Evaluation of the behavior of microorganisms in contact
with antifouling polymer coatings.
• Evaluation of the ability of antifouling polymer coatings
to be combined with release of active compounds (fluo-
ride, chlorhexidine, etc.) to more effectively treat/prevent
caries. Possibilities include entrapping nanoparticles
within coatings for long-term release of antibacterials.
• Testing the ability to design antifouling polymers that
encourage colonization of tooth/device surfaces by
"good" microorganisms over "bad" (acid secreting)
microorganisms.
• Development of methods to improve the residual capac-
ity of fluoride delivery including sustained-release materi-
als, "responsive" release materials (e.g. pH-triggered),
combination therapy (antibiotic/fluoride) release, and
biomaterials that buffer pH.
Conclusion
Successful outcomes of this conference include the pro-
motion of a dialogue between end-users, oral microbiol-
ogists, and materials and bioengineering experts in order
to develop novel prevention technologies and implement
the transfer of such technologies to industry and practice.
Efforts to address the question of what can be done to
more effectively use the large body of basic and applied
caries science already available to speed solutions to the
public health community should be the focus of future
research initiatives.
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